Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: Report of a consensus conference

Journal of Child and Adolescent Psychopharmacology

Volumn 13, Issue 1, 2003, Pages 13-27

  Carlson, Gabrielle A ^k   Hellander, Martha ^c   Kowatch, Robert ^m   Kusumakar, Vivek ^e   Laughren, Thomas ^f   Leibenluft, Ellen ^j   McCracken, James ^l   Nottelmann, Editha ^j   Pine, Daniel ^j   Sachs, Gary ^h   Shaffer, David ^d   Jensen, Peter S ^d   Simar, Renee ⁱ   Strober, Michael ^l   Weller, Elizabeth B ⁿ   Wozniak, Janet ^h   Youngstrom, Eric A ^b   Findling, Robert L ^b   Meyer, Roger E ^a   Calabrese, Joseph ^b   DelBello, Melissa P ^m   Emslie, Graham ^o   Flynn, Laurie ^d   Goodwin, Frederick ^a,g   more..

^a Best Practice   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Child and Adolescent Bipolar Foundation   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e DALHOUSIE UNIVERSITY   (Canada)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h HARVARD UNIVERSITY   (United States)

ⁱ SYNEOS HEALTH   (United States)

^j NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^k STONY BROOK UNIVERSITY   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m UNIVERSITY OF CINCINNATI   (United States)

ⁿ UNIVERSITY OF PENNSYLVANIA   (United States)

^o UNIVERSITY OF TEXAS AT DALLAS   (United States)

more..

Author keywords

Assessment; Bipolar spectrum; Bipolar not otherwise specified (BP NOS); Clinical trials; Ethics; Mania

Indexed keywords

TRANQUILIZER;

ADOLESCENT; BIPOLAR DISORDER; CHILDHOOD DISEASE; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITION; COMORBIDITY; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFORMED CONSENT; LONG TERM CARE; MEDICAL ETHICS; MEDICAL SOCIETY; METHODOLOGY; OUTCOMES RESEARCH; QUESTIONNAIRE; RATING SCALE; SCHOOL CHILD; STANDARD;

EID: 0038556728     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454603321666162     Document Type: Conference Paper

References (42)

1. Altman EG, Hedeker DR, Janicak PG, Peterson JL, Davis JM (1994): The Clinician-Administered Rating Scale for Mania (CARS-M): Development, reliability, and validity. Biol Psychiatry 36(2):124-134.
2. American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association.
3. American Psychiatric Association Task Force for the Handbook of Psychiatric Measures. (2000): Handbook of Psychiatric Measures. Washington, DC, American Psychiatric Association.
4. Asberg M, Montgomery S, Perris C, Schalling D, Sedvall G (1978): A comprehensive psychopathological rating scale. Acta Psychiatr Scand (Suppl) 271:5-27.
5. Bech P, Bolwig TG, Kramp P, Rafaelsen OJ (1979): The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatr Scand 59(4):420-430.
6. Beigel A, Murphy DL (1971): Assessing clinical characteristics of the manic state. Am J Psychiatry 128(6):688-694, 1971.
7. Biederman J, Klein RG, Pine DS, Klein DF (1998): Resolved: Mania is mistaken for ADHD in prepubertal children. J Am Acad Child Adolesc Psychiatry 37(10):1091-1096; discussion 1096-1099.
8. Blackburn IM, Loudon JB, Ashworth CM (1977): A new scale for measuring mania. Psychol Med 7(3):453-458.
9. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garza-Trevino ES, Risch SC, Goodnick PJ, Morris DD (1994): Efficacy of divalproex vs. lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 271(12):918-924.
10. Brierley CE, Szabadi E, Rix KJ, Bradshaw CM (1988): The Manchester Nurse Rating Scales for the daily simultaneous assessment of depressive and manic ward behaviours. J Affect Disord 15(1):45-54.
11. Campbell M, Small AM, Green WH, Jennings SJ, Perry R, Bennett WG, Anderson L (1984): Behavioral efficacy of haloperidol and lithium carbonate: A comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry 41:650-656.
12. Carlson GA (1998): Mania and ADHD: Comorbidity or confusion? [review]. J Affect Disord 51(2):177-187.
13. Carlson GA (1999): Juvenile mania versus ADHD. J Am Acad Child Adolesc Psychiatry 38(4):353-354.
14. Chambers WJ, Puig-Antich J, Hirsch M, Paez P, Ambrosini PJ, Tabrizi MA, Davies M (1985): The assessment of affective disorders in children and adolescents by semi-structured interview. Arch Gen Psychiatry 42:696-702.
15. Charney DS, Nemeroff CB, Lewis L, Laden SK, Gorman JM, Laska EM, Borenstein M, Bowden CL, Caplan A, Emslie GJ, Evans DL, Geller B, Grabowski LE, Herson J, Kalin NH, Keck PE Jr, Kirsch I, Krishnan KR, Kupfer DJ, Makuch RW, Miller FG, Pardes H, Post R, Reynolds MM, Roberts L, Rosenbaum JF, Rosenstein DL, Rubinow DR, Rush AJ, Ryan ND, Sachs GS, Schatzberg AF, Solomon S (2002): Consensus Development Panel: National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry 59(3):262-270.
16. Coccaro EF, Harvey PD, Kupsaw-Lawerence E, Herbert JL, Bernstein DP (1991): Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior. J Neuropsychiatry Clin Neurosci 3:S44-S51.
17. Committee for Proprietary Medicinal Products (CPMP) (2000): Note for Guidance on Clinical Investigation of Medicinal Products in the Paediatric Population (CPMP/ ICH/2711/99-adopted in July 2000). [http://www.emea.eu.int/htms/human/ich/efficacy/ichfin.htm].
18. Committee for Proprietary Medicinal Products (CPMP) (2001): Note for Guidance on Clinical Investigation of Medicinal Products for the Treatment and Prevention of Bipolar Disorder (CPMP/EWP/567/98-adopted in April 2001). [http://www.emea.eu.int/pdfs/human/ewp/056798en.pdf].
19. Emslie G, Rush JA, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J (1997): A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54: 1031-1037.
20. Endicott V, Spitzer RL (1978): A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 35:837-848.
21. First MB, Gibbon M, Spitzer-Williams N, Spitzer RL, Williams JBW (1995): Structured Clinical Interview for DSM-IV (SCID-I) (Users Guide and Interview) Research Version. New York, Biometrics Research Department, New York Psychiatric Institute.
22. Guy W (1976): ECDEU Assessment Manual for Psychopharmacology - Revised (DHEW Publ No ADM 76-388). Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, pp. 218-222.
23. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
24. Heinig SJ, Quon ASW, Meyer RE, Korn D (1999): The changing landscape for clinical research. Acad Med 74:725-745.
25. Herjanic B, Reich W (1977): Differentiating psychiatrically disturbed children on the basis of a structured interview. J Abnorm Child Psychol 5:127-134.
26. Herjanic B, Reich W (1982): Development of a structured psychiatric interview for children: Agreement between child and parent on individual symptoms. J Abnorm Child Psychol 10:307-324.
27. Hughes CW, Rintelmann J, Emslie GJ, Lopez M, MacCabe N (2001): A revised anchored version of the BPRS-C for childhood psychiatric disorders. J Child Adolesc Psychopharmacol 11(1):77-93.
28. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997): Schedule for Affective Disorders and Schiozphrenia for School-Age Children Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-989.
29. Kay SR, Fiszbein A, Opler LA (1987): The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276.
30. Kowatch RA, Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M, Emslie GJ, Weinberg WA, Rush AJ (2000): Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 39(6):713-720.
31. Landgraf JM, Abetz L, Ware JE (1996): The CHG User's Manual, 1st ed. Boston, Health Institute, New England Medical Center.
32. Laughren TP (2001): The scientific and ethical basis for placebocontrolled trials in depression and schizophrenia: An FDA perspective. Eur Psychiatry 16(7):418-423.
33. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D (2002): Research Units on Pediatric Psychopharmacology Autism Network. Risperidone in children with autism and serious behavioral problems. N Engl J Med 347(5):314-321.
34. Michelson D, Faries E, Wernicke J, Kelsey D, Kendrick K, Sallee R, Spencer T, and the Atomoxetine Study Group (2001): Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study. Pediatrics 108:83-91.
35. Montgomery SA, Asberg M (1979): A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389.
36. Overall JE, Gorham DR (1988): The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling. Psychopharmacol Bull 24:97-99.
37. Poznanski EO, Cook SC, Carroll BJ, Corzo H (1983): Use of the Children's Depression Rating Scale in an inpatient psychiatric population. J Clin Psychiatry 44:200-203.
38. Poznanski EO, Freeman LN, Mokros HB (1985): Children's Depression Rating Scale-Revised (September, 1984). Psychopharmacol Bull 21:979-989.
39. Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, Schwab-Stone ME, Lahey BB, Bourdon K, Jensen PS, Bird HR, Canino G, Regier DA (1996): The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): Description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry 35:865-877.
40. Sparrow W, Baila DA, Cicchetti DV (1984): Vineland Adaptive Behavior Scales. Circle Pines, Minnesota, American Guidance Service, Inc.
41. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978): A rating scale for mania: Reliability, validity, and sensitivity. Br J Psychiatry 133:429-435.
42. Zisson S (2001, December): "GSK Forges Ties with Academia." CenterWatch 8(12), pp. 1, 8-12.